A Study of BMS-986249 Alone and in Combination With Nivolumab in Advanced Solid Tumors

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2017
The purpose of this study is to determine whether BMS-986249 both by itself and in combination with Nivolumab is safe and tolerable in the treatment of advanced solid tumors
Epistemonikos ID: 164bd5ee3283c3fb991bf4ba7c204ddbc9b62d14
First added on: May 21, 2024